Tate & Lyle signs exclusive worldwide agreement with University of Nottingham subsidiary for its novel salt reduction technology

31 Oct 2011

| Filed in:

London, UK (31 October 2011) - Tate & Lyle announces that it has signed an exclusive, worldwide license agreement with Eminate Ltd, a wholly owned subsidiary of The University of Nottingham, UK, for its novel salt reduction technology.

The product, currently known as ‘SODA-LO^®’, enables added salt levels to be reduced by up to 30% in foods such as bread, pizza bases, pastry, savoury pie fillings, cheese and baked snacks.

SODA-LO^® is an innovative clean label salt product that enables salt content to be reduced in food without loss of flavour or structure.

Under the license agreement, Tate & Lyle will assume responsibility for commercialising the SODA-LO^® salt reduction technology on a global basis including manufacturing, product development, sales and marketing.

Several well-known food manufacturers, primarily in the UK and USA, are already using SODA-LO^®. Tate & Lyle plans to commence a global rollout of the product in 2012.

Karl Kramer, President of Innovation and Commercial Development at Tate & Lyle said: “The SODA-LO^® salt reduction technology is an excellent addition to Tate & Lyle’s Health & Wellness offering. Salt reduction is a high-profile priority for many of our customers who are committed to formulating reduced salt products to meet growing consumer demand.”

Neil Davidson, Chairman of Eminate Ltd said: “This is a significant deal for Eminate Ltd and we are delighted that Tate & Lyle is working with us and The University of Nottingham to fully commercialise our novel salt reduction technology. Tate & Lyle’s relationships with global food companies and its technical and applications development expertise and resources, will help both parties to maximise commercial value from this exciting technology.”

This technology partnership was assessed and developed by Tate & Lyle’s Open Innovation team, part of its Innovation and Commercial Development group. The Open Innovation team utilises its global network to develop partnerships with universities, customers and start-ups specialising in food science with the goal of successfully bringing their new technologies and products to market.

For all media or general enquiries, please contact Mathew Wootton (details below). If you are a university, start-up business or a similar organization, and want to learn more about Open Innovation at Tate & Lyle, please contact: John Stewart Open Innovation Manager Tate & Lyle Innovation & Commercial Development e: [email protected] Eminate Ltd is a wholly owned subsidiary of The University of Nottingham, founded in 2006, with expertise in the design and commercial application of micro and nano particles, coatings and powders. Eminate Ltd was established with help from a grant from the UK government-backed Technology Strategy Board (www.innovateuk.org), which works to create economic growth by ensuring that the UK is a global leader in innovation. The business operates across a range of sectors including food & ingredients, health, pharmaceuticals, and energy storage. Novel, patented, products have already been developed within the company, and taken to first commercial sale / license, in the food ingredients, functional foods and engineering coatings markets. Eminate’s research and development teams continue to work in close partnership with a range of companies, universities and research organisations to develop new products and provide innovative solutions to commercial challenges. Eminate is based in the East Midlands with offices, research laboratory, and production facilities in Sutton Bonington and Nottingham.

Click here for our press image gallery

About Tate & Lyle:
Supported by our 160-year history of ingredient innovation, we partner with customers to provide consumers with healthier and tastier choices when they eat and drink. We are proud that millions of people around the world consume products containing our ingredients every day.

Through our expertise in sweetening, fortification, and texture, we develop ingredient solutions which reduce sugar, calories, and fat, add fibre and protein, and provide texture and stability in categories including beverages, dairy, bakery, snacks, soups, sauces, and dressings.

We have more than 3,500 employees working in around 57 locations across 39 countries. Science, Solutions, Society is our brand promise and how we will achieve our purpose of Transforming Lives Through the Science of Food. By living our purpose we believe we can successfully grow our business and have a positive impact on society. We live our purpose in three ways, by supporting healthy living, building thriving communities and caring for our planet.

Tate & Lyle is listed on the London Stock Exchange under the symbol TATE.L. American Depositary Receipts trade under TATYY. In the year to 31 March 2023, Tate & Lyle revenue from continuing operations totalled £1.75 billion. For more information, please visit https://www.tateandlyle.com or follow Tate & Lyle on Twitter, Linkedin, Facebook or YouTube.

Previous press release Tate & Lyle opens new Global Shared Services Centre in Łódź, Poland

View all Press releases

Next press release Tate & Lyle PLC Half Year Results Announcement - Nov 2011